Hoffman William's Form 4 filing
Inari Medical, Inc. (NARI) · filed Nov 9, 2021
- Accession no.
- 0001562180-21-006922
- Filed
- Nov 9, 2021
- Trade date
- Nov 5, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 0 derivative transactions. Open-market sales total $2.74M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hoffman WilliamCIK 0001304099 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 5, 2021 | Common Stock | SSaleDisposed | −11,622 | $90.08 | −$1,046,909.76 | 558,747 | Direct | |
| Nov 5, 2021 | Common Stock | SSaleDisposed | −10,096 | $90.82 | −$916,918.72 | 548,651 | Direct | |
| Nov 5, 2021 | Common Stock | SSaleDisposed | −3,020 | $92.53 | −$279,440.6 | 545,631 | Direct | |
| Nov 5, 2021 | Common Stock | SSaleDisposed | −4,312 | $93.64 | −$403,775.68 | 541,319 | Direct | |
| Nov 5, 2021 | Common Stock | SSaleDisposed | −950 | $94.24 | −$89,528 | 540,369 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.